Repl Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law Business Wire (Press Release) 22:13 Fri, 07 Aug
Deadline Soon: Replimune Group, Inc. (Repl) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business Wire (Press Release) 19:50 Fri, 07 Aug
Deadline Approaching: Replimune Group, Inc. (Repl) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith Business Wire (Press Release) 19:40 Fri, 07 Aug
Deadline Alert: Replimune Group, Inc. (Repl) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit Business Wire (Press Release) 19:40 Fri, 07 Aug
Replimune’s Tudriqev wins FDA accelerated approval for melanoma BioWorld 19:05 Fri, 07 Aug Article paywall
STAT Plus: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more STAT 16:07 Fri, 07 Aug
Law Offices of Howard G. Smith Encourages Replimune Group, Inc. (Repl) Shareholders to Inquire About Securities Fraud Class Action Business Wire (Press Release) 15:05 Fri, 07 Aug
Law Offices of Frank R. Cruz Encourages Replimune Group, Inc. (Repl) Shareholders To Inquire About Securities Fraud Class Action Business Wire (Press Release) 14:04 Fri, 07 Aug
Stockholder Alert: Robbins LLP Informs Investors of the Replimune Group, Inc. Class Action Business Wire (Press Release) 04:33 Fri, 07 Aug
Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - Repl PR Newswire (Press Release) 02:59 Fri, 07 Aug
Repl class action notice: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Replimune Group, Inc. Investors Business Wire (Press Release) 01:10 Fri, 07 Aug
Repl shareholder alert: Replimune Group Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Business Wire (Press Release) 01:07 Wed, 05 Aug
Why Replimune (REPL) Is Up 15.5% After Supportive FDA Panel Vote On IGNYTE Melanoma Data Simply Wall St 16:17 Sat, 01 Aug
Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote Benzinga 15:13 Fri, 31 Jul Article paywall
STAT Plus: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more STAT 14:32 Fri, 31 Jul
FDA Advisory Panel Backs Replimune's RP1, Bringing The Melanoma Therapy One Step Closer To Approval RTT News 10:23 Fri, 31 Jul
Securities Fraud Investigation Into Replimune Group Inc. (Repl) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire (Press Release) 20:17 Wed, 29 Jul
Replimune Group Inc. (Repl) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire (Press Release) 20:07 Wed, 29 Jul
Securities Fraud Investigation Into Replimune Group Inc. (Repl) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire (Press Release) 01:46 Wed, 29 Jul
Replimune’s rollercoaster: FDA adcom signals another bumpy ride BioWorld 22:13 Tue, 28 Jul Article paywall
Replimune shares fall after FDA reviewers raise doubts over RP1 melanoma drug efficacy Proactive Investors (US) 18:04 Tue, 28 Jul
